Lymphoma, Malignant
specificA malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
8
Centers
4
Active Trials
—
Cancer Funding
Top Centers for Lymphoma, Malignant(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 67.5 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 67.5 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 67.5 |
| 4 | Boston University Cancer CenterBoston, MA Active Research Program | 67.5 |
| 5 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 45.0 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 45.0 |
| 7 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 45.0 |
| 8 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 45.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →